Skip to content

Bridging Recovery Allies in Virtual Environments

Bridging Recovery Allies in Virtual Environments (BRAVE)-Understanding Feasibility and Acceptability of Using Virtual Environments for Social Communication in Persons With TBI

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT03582228
Acronym
BRAVE
Enrollment
13
Registered
2018-07-10
Start date
2018-08-06
Completion date
2019-01-30
Last updated
2019-04-16

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Traumatic Brain Injury

Keywords

Virtual Environments, Social Communication

Brief summary

The Bridging Recovery Allies in Virtual Environments (BRAVE) study aims to evaluate the acceptability and feasibility of implementing a virtual environment (VE) social support group for social communication training among adults with traumatic brain injury (TBI).

Interventions

BEHAVIORALVirtual Envrionment for Social Communication

Once the Virtual Envrionment for Social Communication intervention begins, participants will meet online from home for one-hour sessions twice a week (twelve sessions over six weeks). Weekly sessions will follow a standardized format: * 15 minutes- Social support group (guided discussion of experiences related to weekly topic) * 20 minutes- Didactic instruction * 15 minutes- Role playing * 10 minutes- Debriefing and group feedback

Sponsors

The Institute for Rehabilitaion and Research Foundation
CollaboratorOTHER
The University of Texas Health Science Center, Houston
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* subjects with a traumatic brain injury * between the age of 18 and 80 * living in the community * able to read and speak English, * are more than 1-year post-injury * are accessible by phone, * report independent computer usage over the last 6 months * have access to a computer meeting minimum specifications for the Learning in Virtual Environments (LIVE) platform (requires Windows) * have broadband Internet connection, * achieve a Galveston Orientation Assessment Test (GOAT) score \>75 to ensure appropriate levels of cognition for the study * and score \>93.8 on the Western Battery Aphasia-Revised (WAB-R) scale to indicate sufficient communicative abilities to participate in a social support group and exit interview group. * able to understand and independently consent for the study and provide written consent prior to enrollment in the study

Exclusion criteria

\- verbal communication impairments will be excluded as measured by the WAB-R, as this study intends to focus on persons with social communication deficits rather than verbal deficits.

Design outcomes

Primary

MeasureTime frameDescription
Perceived Usability as Assessed by the System Usability Scale (SUS)about 1 week after the end of the interventionScores on the System Usability Scale (SUS) range from 0-100, with higher scores indicating greater usability (which is the desired outcome).
Acceptability as Assessed by the Acceptability E-Scaleabout 1 week after the end of the interventionScores on the Acceptability E-scale range from 6-30, with higher scores indicating greater acceptability (which is the desired outcome).
Feasibility as Assessed by Participation Ratefrom the start of the intervention to the end of the intervention (6 weeks)Scores on the LaTrobe Social Communication Questionnaire (LCQ) range from 30-120, with lower score indicating less social communication impairment (which is the desired outcome).
Feasibility as Assessed by Attrition Ratefrom the start of the intervention to the end of the intervention (6 weeks)

Secondary

MeasureTime frame
Change in Social Communication as Assessed by the LaTrobe Communication Questionnaire (LCQ)baseline, about 1 week after the end of the intervention

Countries

United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026